ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

(S)-tert-Butyl 4-(1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate → (S)-4-Amino-N-(1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethyl)tetrahydro-2H-pyran-4-carboxamide

HRID 216943
印刷

反応式

HRID 216943 の反応式
[C:1]([C@@H:3]([NH:22][C:23]([C:25]1([NH:31]C(=O)OC(C)(C)C)[CH2:30][CH2:29][O:28][CH2:27][CH2:26]1)=[O:24])[CH2:4][C:5]1[CH:10]=[CH:9][C:8]([C:11]2[CH:12]=[CH:13][C:14]3[O:18][C:17](=[O:19])[N:16]([CH3:20])[C:15]=3[CH:21]=2)=[CH:7][CH:6]=1)#[N:2]>C(O)=O>[NH2:31][C:25]1([C:23]([NH:22][C@H:3]([C:1]#[N:2])[CH2:4][C:5]2[CH:6]=[CH:7][C:8]([C:11]3[CH:12]=[CH:13][C:14]4[O:18][C:17](=[O:19])[N:16]([CH3:20])[C:15]=4[CH:21]=3)=[CH:9][CH:10]=2)=[O:24])[CH2:26][CH2:27][O:28][CH2:29][CH2:30]1
参加物実験手順後処理出典と根拠反応ノート

参加物

3

反応物 1

HCID 59568548(S)-tert-Butyl 4-(1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate

生成物 1

HCID 49783826(S)-4-Amino-N-(1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethyl)tetrahydro-2H-pyran-4-carboxamide収率 40.1%

試薬・触媒・溶媒 1

HCID 284Formic Acid溶媒

実験手順

(S)-tert-Butyl 4-(1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate (Example 17, step (ii), 145 mg) (crude mixture) was dissolved in formic acid (3 mL) and the mixture stirred at room temperature for 18 h. The mixture was evaporated to dryness, dissolved in methanol (10 mL), re-evaporated to dryness, dissolved in methanol/acetonitrile 50:50 (4 mL) and purified on reversed phase HPLC eluting with methanol in 0.1% aqueous TFA on a Water's SunFire column. The material was converted to free base by evaporating the relevant fractions, dissolving in ethyl acetate (20 mL) and shaking with saturated aqueous sodium bicarbonate solution (20 mL). The sodium bicarbonate was further extracted with ethyl acetate (20 mL). The combined extracts were dried over magnesium sulfate and evaporated to afford the titled compound (47 mg).

後処理

  1. customThe mixture was evaporated to dryness
  2. dissolutiondissolved in methanol (10 mL)
  3. customre-evaporated to dryness
  4. dissolutiondissolved in methanol/acetonitrile 50:50 (4 mL)
  5. custompurified on reversed phase HPLC
  6. washeluting with methanol in 0.1% aqueous TFA on a Water'
  7. customby evaporating the relevant fractions
  8. dissolutiondissolving in ethyl acetate (20 mL)
  9. stirringshaking with saturated aqueous sodium bicarbonate solution (20 mL)
  10. extractionThe sodium bicarbonate was further extracted with ethyl acetate (20 mL)
  11. dry with materialThe combined extracts were dried over magnesium sulfate
  12. customevaporated

出典と根拠

ORDレコード
ord-e9d924bd4ab74b7a9fda4b0b1f80deac
出典データセット
uspto-grants-2012_06
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08193239B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート